E
Vor Biopharma Inc. VOR
$0.5671 -$0.0229-3.88%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Total Cash And Short-Term Investments 46.36% -26.91% -20.04% -21.65% -14.32%
Total Receivables -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -0.02% 3.86% 5.61% 21.50% -14.16%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets 33.33% 4.78% -46.35% 6.74% -28.79%
Total Current Assets 43.41% -25.44% -19.28% -20.59% -14.37%

Total Current Assets 43.41% -25.44% -19.28% -20.59% -14.37%
Net Property, Plant & Equipment -4.99% -4.55% -4.43% -4.23% -3.82%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -2.62% -10.06% -24.28% 0.10% 11.17%
Total Assets 23.19% -18.08% -15.23% -15.70% -11.16%

Total Accounts Payable 14.36% -34.43% -13.68% 185.28% -37.74%
Total Accrued Expenses 45.41% 15.43% 10.82% -36.57% 5.72%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current 1.25% 1.22% 3.94% 3.32% 2.32%
Total Finance Division Other Current Liabilities -- -- -- -- --
Total Other Current Liabilities -- -- -- -- --
Total Current Liabilities 29.75% 3.94% 4.45% -15.15% 1.20%

Total Current Liabilities 29.75% 3.94% 4.45% -15.15% 1.20%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -3.75% -3.42% -3.49% -3.29% -3.12%
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities 7.41% -1.08% -1.11% -7.19% -1.74%

Common Stock & APIC 10.91% 0.46% 0.58% 0.64% 0.41%
Retained Earnings -7.20% -6.91% -7.51% -9.06% -8.37%
Treasury Stock & Other -67.65% 197.14% 19.54% -12.99% 72.50%
Total Common Equity 32.50% -25.62% -20.28% -18.37% -13.76%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 32.50% -25.62% -20.28% -18.37% -13.76%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 32.50% -25.62% -20.28% -18.37% -13.76%

Weiss Ratings